-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Trade Alert: The Founder Of EuroEyes International Eye Clinic Limited (HKG:1846), Jörn Jörgensen, Has Just Spent HK$383k Buying A Few More Shares
Trade Alert: The Founder Of EuroEyes International Eye Clinic Limited (HKG:1846), Jörn Jörgensen, Has Just Spent HK$383k Buying A Few More Shares
Whilst it may not be a huge deal, we thought it was good to see that the EuroEyes International Eye Clinic Limited (HKG:1846) Founder, Jörn Jörgensen, recently bought HK$383k worth of stock, for HK$6.96 per share. Nevertheless, it only increased their shareholding by a minuscule percentage, and it wasn't a massive purchase by absolute value, either.
See our latest analysis for EuroEyes International Eye Clinic
The Last 12 Months Of Insider Transactions At EuroEyes International Eye Clinic
In fact, the recent purchase by Founder Jörn Jörgensen was not their only acquisition of EuroEyes International Eye Clinic shares this year. Earlier in the year, they paid HK$11.63 per share in a HK$2.6m purchase. That means that even when the share price was higher than HK$6.74 (the recent price), an insider wanted to purchase shares. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. To us, it's very important to consider the price insiders pay for shares. As a general rule, we feel more positive about a stock if insiders have bought shares at above current prices, because that suggests they viewed the stock as good value, even at a higher price.
In the last twelve months EuroEyes International Eye Clinic insiders were buying shares, but not selling. The average buy price was around HK$8.82. I'd consider this a positive as it suggests insiders see value at around the current price. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
SEHK:1846 Insider Trading Volume July 12th 2022There are always plenty of stocks that insiders are buying. So if that suits your style you could check each stock one by one or you could take a look at this free list of companies. (Hint: insiders have been buying them).
Insider Ownership of EuroEyes International Eye Clinic
I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. EuroEyes International Eye Clinic insiders own about HK$1.2b worth of shares (which is 55% of the company). I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.
What Might The Insider Transactions At EuroEyes International Eye Clinic Tell Us?
The recent insider purchases are heartening. And an analysis of the transactions over the last year also gives us confidence. When combined with notable insider ownership, these factors suggest EuroEyes International Eye Clinic insiders are well aligned, and quite possibly think the share price is too low. Nice! Of course, the future is what matters most. So if you are interested in EuroEyes International Eye Clinic, you should check out this free report on analyst forecasts for the company.
Of course EuroEyes International Eye Clinic may not be the best stock to buy. So you may wish to see this free collection of high quality companies.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
虽然这可能不是什么大事,但我们认为很高兴看到欧洲眼国际眼科诊所有限公司(HKG:1846)创办人JöRn Jörgensen最近以每股6.96港元的价格购入价值38.3万港元的股票。尽管如此,他们的持股比例只增加了很小一部分,从绝对值来看,这也不是大规模收购。
查看我们对欧洲眼国际眼科诊所的最新分析
欧洲眼国际眼科诊所最近12个月的内幕交易
事实上,创始人JöRn Jörgensen最近的收购并不是他们今年唯一一次收购Euroyes国际眼科诊所的股票。今年早些时候,他们以每股11.63港元的价格收购了260万港元。这意味着,即使股价高于6.74港元(最近的价格),也有内部人士想要购买股票。尽管他们的观点可能在收购后发生了变化,但这至少表明他们对公司的未来充满信心。对我们来说,考虑内部人士为股票支付的价格非常重要。一般来说,如果内部人士以高于当前价格的价格买入一只股票,我们对这只股票的看法会更积极,因为这表明他们认为这只股票很有价值,即使价格更高。
在过去的12个月里,欧洲眼国际眼科诊所的内部人士在买入股票,但没有卖出。平均买入价约为8.82港元。我认为这是积极的,因为它表明内部人士认为价值在当前价格附近。你可以在下面看到过去12个月(由公司和个人)进行的内幕交易的直观描述。如果你点击图表,你可以看到所有的个人交易,包括股票价格、个人和日期!
联交所:2022年7月12日内幕交易量1,846内部人士总是在买入大量股票。因此,如果这适合你的风格,你可以逐一检查每一种库存,或者你可以看看这个免费公司名单。(提示:内部人士一直在买入这些股票)。
欧洲眼国际眼科诊所的内部人所有权
我喜欢看内部人士在一家公司持有多少股份,以帮助我了解他们与内部人士的关系。通常,内部人持股越高,内部人就越有可能受到激励,建立长期的公司。Euroyes International Eye Clinic内部人士持有价值约12亿港元的股份(占该公司55%的股份)。我喜欢看到这种程度的内部人持股,因为它增加了管理层考虑股东最佳利益的机会。
欧洲眼国际眼科诊所的内幕交易可能告诉我们什么?
最近的内部收购令人振奋。对过去一年交易的分析也给了我们信心。再加上值得注意的内部人士持股,这些因素表明,欧洲眼国际眼科诊所的内部人士非常一致,很可能认为股价太低了。好的!当然了,未来才是最重要的。所以,如果你对欧洲眼国际眼科诊所感兴趣,你应该去看看这个免费分析师对该公司的预测报告。
当然了欧洲眼国际眼科诊所可能不是最值得买入的股票。所以你可能想看看这个免费汇集了高质量的公司。
就本文而言,内部人是指向相关监管机构报告其交易的个人。我们目前负责公开市场交易和私人处置,但不包括衍生品交易。
对这篇文章有什么反馈吗?担心内容吗? 保持联系直接与我们联系。或者,也可以给编辑组发电子邮件,地址是implywallst.com。
本文由Simply Wall St.撰写,具有概括性。我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论,我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议,也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意,我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。Simply Wall St.对上述任何一只股票都没有持仓。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧